-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Regeneron Pharmaceuticals Says Libtayo Achieves 37% Reduction In Risk Of Death At 44 Months (Hr 0.63)

Reuters·10/25/2026 09:17:53

Please log in to view news